[1]
|
Kurlander, J.E. and Drossman, D.A. (2014) Diagnosis and Treatment of Narcotic Bowel Syndrome. Nature Reviews Gastroenterology & Hepatology, 11, 410-418. https://doi.org/10.1038/nrgastro.2014.53
|
[2]
|
Balbale, S.N., Cao, L., Trivedi, I., Stulberg, J.J., Suda, K.J., Gellad, W.F., Evans, C.T., Lambert, B.L., Jordan, N. and Keefer, L.A. (2021) High-Dose Opioid Use among Veterans with Unexplained Gastrointestinal Symptoms Versus Structural Gastrointestinal Diagnoses. Digestive Diseases and Sciences, 66, 3938-3950.
https://doi.org/10.1007/s10620-020-06742-0
|
[3]
|
Koob, G.F., Arends, M.A., McCracken, M.L., et al. (2023) Opi-oids. Neurobiology of Addiction Series, 4, 1-400.
https://doi.org/10.1016/B978-0-12-816988-9.00001-1
|
[4]
|
DiCello, J.J., Carbone S.E., Saito, A., Rajasekhar, P., Ceredig, R.A., Pham, V., Valant, C., Christopoulos, A., Veldhuis, N.A., Canals, M., Massotte, D. and Poole, D.P. (2020) Mu and Delta Opioid Receptors Are Coexpressed and Functionally Interact in the Enteric Nervous System of the Mouse Colon. Cellular and Molecular Gastroenterology and Hepatology, 9, 465-483. https://doi.org/10.1016/j.jcmgh.2019.11.006
|
[5]
|
Kraichely, R.E., Arora, A.S. and Murray, J.A. (2010) Opi-ate-Induced Oesophageal Dysmotility. Alimentary Pharmacology & Therapeutics, 31, 601-606. https://doi.org/10.1111/j.1365-2036.2009.04212.x
|
[6]
|
Sharma, V., Rana, S.S., Chaudhary, V., Dhaka, N., Manrai, M., Sivalingam, J., Sharma, R., Dutta, U. and Bhasin, D.K. (2016) Opium-Related Sphincter of Oddi Dysfunction Causing Double Duct Sign. Endoscopic Ultrasound, 5, 269-271.
https://doi.org/10.4103/2303-9027.187892
|
[7]
|
Nojkov, B., Baker, J., Menees, S., Watts, L., Collins, K., Arm-strong, M., Thibault, M., Harer, K., Lee, A., Eswaran, S., Saad, R. and Chey, W.D. (2019) Is Dyssynergic Defecation an Unrecognized Cause of Chronic Constipation in Patients Using Opioids? American Journal of Gastroenterology, 114, 1772-1777.
https://doi.org/10.14309/ajg.0000000000000413
|
[8]
|
Crockett, S.D., Greer, K.B., Heidelbaugh, J.J., Falck-Ytter, Y., Hanson, B.J. and Sultan, S. (2019) American Gastroenterological Association Institute Clinical Guidelines Committee. American Gastroenterological Association Institute Guideline on the Medical Management of Opioid-Induced Constipa-tion. Gastroenterology, 156, 218-226.
https://doi.org/10.1053/j.gastro.2018.07.016
|
[9]
|
Farmer, A.D., Drewes, A.M., Chiarioni, G., De Giorgio, R., O’Brien, T., Morlion, B. and Tack, J. (2019) Pathophysiology and Management of Opioid-Induced Constipation: Euro-pean Expert Consensus Statement. United European Gastroenterology Journal, 7, 7-20. (Erratum in: United European Gastroenterology Journal, 7, 178.)
https://doi.org/10.1177/2050640618818305
|
[10]
|
De Giorgio, R., Zucco, F.M., Chiarioni, G., Mercadante, S., Co-razziari, E.S., Caraceni, A., Odetti, P., Giusti, R., Marinangeli, F. and Pinto, C. (2021) Management of Opioid-Induced Constipation and Bowel Dysfunction: Expert Opinion of an Italian Multidisciplinary Panel. Advances in Therapy, 38, 3589-3621.
https://doi.org/10.1007/s12325-021-01766-y
|
[11]
|
Oak, A.A., Chu, T., Yottasan, P., Chhetri, P.D., Zhu, J., Du Bois, J. and Cil, O. (2022) Lubiprostone Is Non-Selective Activator of cAMP-Gated Ion Channels and Clc-2 Has a Mi-nor Role in Its Prosecretory Effect in Intestinal Epithelial Cells. Molecular Pharmacology, 102, 106-115. https://doi.org/10.1124/molpharm.122.000542
|
[12]
|
Li, Y., Yu, H., Xu, B., Yuan, F., Zhang, P., Tu, S., Zhou, Y. and Li, X. (2023) Pharmacokinetics and Bioequivalence of the Lubiprostone Capsule in Healthy Chinese Subjects. Clini-cal Pharmacology in Drug Development, 12, 436-446.
https://doi.org/10.1002/cpdd.1212
|
[13]
|
Xiao, Y.L., Dai, N., He, S.X., Tian, A., Liu, S., Tian, Z.B., Wang, X.Y., Li, Y.Q., Hou, X.H., Fang, X.C., Wen, Z.L., Zeng, W.Z., Xu, H., Sun, M.J., Liu, Y.L., Wu, Y.D., Shen, X.Z., Liu, X.W., Liu, L. and Chen, M.H. (2021) Efficacy and Safety of Lubiprostone for the Treatment of Functional Constipation in Chi-nese Adult Patients: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial. Journal of Digestive Diseases, 22, 622-629.
https://doi.org/10.1111/1751-2980.13058
|
[14]
|
Smart, C.J. and Malik, K.I. (2017) Prucalopride for the Treatment of Ileus. Expert Opinion on Investigational Drugs, 26, 489-493. https://doi.org/10.1080/13543784.2017.1301427
|
[15]
|
Webster, L.R., Michna, E., Khan, A., Israel, R.J. and Harper, J.R. (2017) Long-Term Safety and Efficacy of Subcutaneous Methylnaltrexone in Patients with Opioid-Induced Consti-pation and Chronic Noncancer Pain: A Phase 3, Open- Label Trial. Pain Medicine, 18, 1496-1504. https://doi.org/10.1093/pm/pnx148
|
[16]
|
Kanemasa, T., Koike, K., Takase, K., Arai, T., Nakamura, A., Morioka, Y. and Hasegawa, M. (2020) Pharmacological Profile of Naldemedine, a Peripherally Acting μ-Opioid Receptor Antagonist: Comparison with Naloxone and Naloxegol. Journal of Pharmacology and Experimental Therapeutics, 373, 438-444. https://doi.org/10.1124/jpet.119.264515
|
[17]
|
Saini, H.S., Alvi, Z., Singh, B., Elsharkawy, B. and Yasir, M. (2020) Methylnaltrexone and Naloxone for Opioid-Induced Constipation in the Critical Care Setting. Cureus, 12, e6829. https://doi.org/10.7759/cureus.6829
|
[18]
|
Sturaro, C., Malfacini, D., Argentieri, M., Djeujo, F.M., Marzola, E., Al-banese, V., Ruzza, C., Guerrini, R., Calo, G. and Molinari, P. (2022) Pharmacology of Kappa Opioid Receptors: Novel Assays and Ligands. Frontiers in Pharmacology, 13, 873082. https://doi.org/10.3389/fphar.2022.873082
|
[19]
|
Bohn, L.M., Lefkowitz, R.J., Gainetdinov, R.R., Peppel, K., Caron, M.G. and Lin, F.T. (1999) Enhanced Morphine Analgesia in Mice Lacking Beta-Arrestin 2. Science, 286, 2495-2498. https://doi.org/10.1126/science.286.5449.2495
|
[20]
|
王莉娜, 刘杰, 李道睿, 等. 通腑方治疗阿片类药物引起便秘的疗效观察[J]. 中国中西医结合外科杂志, 2010, 16(1): 116-119.
|
[21]
|
马超, 赵婷. 大黄穴位贴敷神阙穴治疗恶性肿瘤患者阿片类药物所致便秘的效果研究[J]. 首都食品与医药, 2023, 30(15): 141-143. https://doi.org/10.3969/j.issn.1005-8257.2023.15.047
|
[22]
|
吴丽琴, 李毅, 童德萍, 等. 中药敷脐治疗癌痛患者口服阿片类药物导致气虚津亏型便秘的临床疗效[J]. 重庆医学, 2019, 48(16): 2764-2766+2771. https://doi.org/10.3969/j.issn.1671-8348.2019.16.015
|
[23]
|
胡志萍. 阿片类药物导致便秘的中医治疗浅谈[J]. 药品评价, 2012, 9(12): 42-43.
https://doi.org/10.3969/j.issn.1672-2809.2012.12.011
|